Latest Investment News

Alchemy Resources is set to begin reverse circulation drilling at its Roe Hills lithium project in Western Australia, following promising aircore results. The drilling forms part of a joint venture with JOGMEC, aiming to unlock significant lithium potential along a major structural trend.

Dreadnought Resources reports a 36% increase in high-grade gold resources at Star of Mangaroon, secures $18 million in funding, and advances critical metals projects with promising drilling results and strategic partnerships.

Banco Santander has launched A$550 million of fixed rate senior notes due in 2031, exclusively aimed at professional and eligible counterparties under MiFID II regulations. The notes will be listed on the ASX and carry investment-grade ratings.

Banco Santander has launched a A$450 million tranche of floating rate senior notes due in 2031, targeting exclusively professional and eligible counterparties under MiFID II regulations. The notes offer a quarterly interest rate tied to the 3-month BBSW plus a margin of 0.97%.

NEXTDC has obtained the crucial planning permit to develop its M4 Melbourne Data Centre in Port Melbourne, marking a significant step in expanding its infrastructure footprint.

Finder Energy has completed a $5.2 million capital raise through a share placement to its directors and substantial shareholder Longreach Capital, following shareholder approval.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Eagle Mountain Mining has issued nearly 120 million new shares and 40 million options, raising just over $1 million, but a significant shortfall remains to be placed. The company aims to secure additional funding to advance its Arizona copper-gold projects.

Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.

1414 Degrees secures critical approvals from AEMO and ElectraNet for its 140 MW Aurora Battery Energy Storage System, advancing the project toward grid connection and commercial operation in 2026.